×

Gilead's HIV Crusade

8:15 AM ET Fri, 1 Dec 2006

Today is World AIDS Day, and CNBC takes a look at Gilead, a pharma company whose portfolio includes several HIV treatments. CNBC's Joe Kernen interviews John Martin, Gilead Sciences CEO.